ATI Physical Therapy (ATIP) Competitors

$5.00
+0.01 (+0.20%)
(As of 05/17/2024 ET)

ATIP vs. BIAF, BNTC, ZIVO, DMTK, MEIP, CPIX, HLTH, PAVM, ORGS, and NEPH

Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include bioAffinity Technologies (BIAF), Benitec Biopharma (BNTC), ZIVO Bioscience (ZIVO), DermTech (DMTK), MEI Pharma (MEIP), Cumberland Pharmaceuticals (CPIX), Cue Health (HLTH), PAVmed (PAVM), Orgenesis (ORGS), and Nephros (NEPH). These companies are all part of the "medical" sector.

ATI Physical Therapy vs.

bioAffinity Technologies (NASDAQ:BIAF) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment.

1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 36.4% of bioAffinity Technologies shares are held by insiders. Comparatively, 0.9% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ATI Physical Therapy has a net margin of -8.15% compared to ATI Physical Therapy's net margin of -171.43%. bioAffinity Technologies' return on equity of 0.00% beat ATI Physical Therapy's return on equity.

Company Net Margins Return on Equity Return on Assets
bioAffinity Technologies-171.43% -134.34% -95.83%
ATI Physical Therapy -8.15%N/A -5.04%

bioAffinity Technologies has a beta of 3.15, suggesting that its share price is 215% more volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500.

ATI Physical Therapy received 15 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.

CompanyUnderperformOutperform
bioAffinity TechnologiesN/AN/A
ATI Physical TherapyOutperform Votes
15
36.59%
Underperform Votes
26
63.41%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
bioAffinity Technologies
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
ATI Physical Therapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

bioAffinity Technologies has higher earnings, but lower revenue than ATI Physical Therapy. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$2.53M10.42-$7.94M-$0.93-2.43
ATI Physical Therapy$699.02M0.03-$69.79M-$28.92-0.17

In the previous week, bioAffinity Technologies had 2 more articles in the media than ATI Physical Therapy. MarketBeat recorded 3 mentions for bioAffinity Technologies and 1 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of -0.32 beat bioAffinity Technologies' score of -1.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.

Company Overall Sentiment
bioAffinity Technologies Neutral
ATI Physical Therapy Negative

Summary

bioAffinity Technologies and ATI Physical Therapy tied by winning 7 of the 14 factors compared between the two stocks.

Get ATI Physical Therapy News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATIP vs. The Competition

MetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE Exchange
Market Cap$21.98M$554.14M$5.24B$18.14B
Dividend YieldN/AN/A44.24%3.44%
P/E Ratio-0.175.0694.4921.91
Price / Sales0.030.252,373.7210.59
Price / Cash0.835.1536.7919.24
Price / Book-0.191.965.496.00
Net Income-$69.79M-$225.94M$105.95M$966.17M
7 Day Performance1.01%-0.10%1.42%1.85%
1 Month Performance24.69%10.06%4.96%6.59%
1 Year Performance-52.43%-20.59%7.84%23.69%

ATI Physical Therapy Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIAF
bioAffinity Technologies
0 of 5 stars
$1.87
-6.0%
N/A+27.0%$21.52M$2.53M-2.0814Gap Up
BNTC
Benitec Biopharma
1.4026 of 5 stars
$8.43
+3.8%
$16.00
+89.8%
+183.4%$21.83M$80,000.000.0016Upcoming Earnings
ZIVO
ZIVO Bioscience
0 of 5 stars
$7.83
flat
N/A-55.4%$22.08M$30,000.00-1.718Earnings Report
Gap Down
DMTK
DermTech
0.5964 of 5 stars
$0.64
+3.2%
$2.38
+272.5%
-79.8%$22.09M$15.30M-0.20206Positive News
MEIP
MEI Pharma
4.0159 of 5 stars
$3.16
+1.3%
$7.00
+121.5%
-57.9%$21.05M$48.82M0.8146Analyst Forecast
CPIX
Cumberland Pharmaceuticals
0 of 5 stars
$1.57
-1.3%
N/A-14.2%$22.26M$39.55M-2.6691Analyst Forecast
Short Interest ↑
Gap Up
HLTH
Cue Health
0.7354 of 5 stars
$0.13
+8.2%
$3.00
+2,174.5%
-88.2%$20.98M$70.94M-0.05726Short Interest ↑
Gap Up
PAVM
PAVmed
2.1594 of 5 stars
$2.22
+15.6%
$21.00
+845.9%
-73.5%$20.94M$2.45M-0.24107Upcoming Earnings
Analyst Upgrade
Analyst Revision
News Coverage
Gap Up
ORGS
Orgenesis
0 of 5 stars
$0.60
flat
N/A-50.7%$20.79M$530,000.00-0.66146Upcoming Earnings
NEPH
Nephros
2.3311 of 5 stars
$2.14
+1.9%
N/A+87.3%$22.56M$14.24M-15.2931Analyst Forecast
Insider Buying
News Coverage
Gap Up

Related Companies and Tools

This page (NYSE:ATIP) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners